Literature DB >> 1891452

Immunological recognition of larval Taenia crassiceps glycolipids by sera from parasite-infected mice.

J Kunz1, S Baumeister, R D Dennis, B Küytz, H Wiegandt, E Geyer.   

Abstract

The isolation and purification of a neutral glycolipid fraction from Taenia crassiceps metacestodes (KBS strain), harvested from both male and female NMRI mice at 70-80 days following intraperitoneal infection, revealed 24 thin-layer chromatography-designated glycolipid bands. The glycolipids were defined as ceramide mono- (n = 3), di- (n = 3), tri- (n = 4), tetra- (n = 5), and greater than tetrasaccharides (n = 9) according to their running properties as defined by thin-layer chromatography against standards of known structure. The defined glycolipids were tested for immunoreactivity with sera from noninfected and T. crassiceps-infected NMRI mice (intraperitoneal injection or implantation of 15 larvae/animal) using the enzyme-linked immunosorbent assay (ELISA) until day 33 p.i. (IgM and IgG reaction) and high-performance thin-layer chromatography (HPTLC) combined with immunostaining (IgG reaction) until day 7 p.i. ELISA-determined IgM and IgG titres were significantly elevated from day 5 p.i. Immunostaining revealed early reactivity for certain ceramide tetra- and greater than tetrasaccharides (n = 6) on day 3 p.i. From day 5 p.i. onwards, nearly all glycolipids, including ceramide mono- and disaccharides, were recognized by the sera from metacestode-challenged mice. On day 7 p.i., a total of 22 bands were serologically active; of these, a considerable number (n = 10) showed increased staining intensity. Remarkably, in many cases (10 of 20), 3 glycolipids (tetra- and greater than tetrasaccharides) were weakly recognized by mouse sera taken before infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891452     DOI: 10.1007/bf00931642

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  15 in total

1.  Identification of Schistosoma mansoni glycolipids that share immunogenic carbohydrate epitopes with glycoproteins.

Authors:  J B Weiss; J L Magnani; M Strand
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

2.  Human monoclonal antibodies associated with neuropathy.

Authors:  R H Quarles
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

Review 3.  The two antibody specificities within human anti-blood group B antibodies.

Authors:  U Galili
Journal:  Transfus Med Rev       Date:  1988-06

4.  Elevated cerebroside antibody levels in human visceral and cutaneous leishmaniasis, Trypanosoma rangeli infection, and chronic Chagas' disease.

Authors:  J L Avila; M Rojas
Journal:  Am J Trop Med Hyg       Date:  1990-07       Impact factor: 2.345

Review 5.  Studies on natural antibodies and autoantibodies.

Authors:  S Avrameas; G Dighiero; P Lymberi; B Guilbert
Journal:  Ann Immunol (Paris)       Date:  1983 Jul-Aug

6.  Detection of glycolipid ligands by direct binding of carbohydrate-binding proteins to thin-layer chromatograms.

Authors:  J L Magnani; M Brockhaus; D F Smith; V Ginsburg
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

7.  Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component.

Authors:  R W Ledeen; R K Yu; L F Eng
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

8.  Quantitative isolation of total glycosphingolipids from animal cells.

Authors:  T Saito; S I Hakomori
Journal:  J Lipid Res       Date:  1971-03       Impact factor: 5.922

9.  Glycosphingolipids in insects. Chemical structures of ceramide monosaccharide, disaccharide, and trisaccharide from pupae of Calliphora vicina (Insecta: Diptera).

Authors:  R D Dennis; R Geyer; H Egge; H Menges; S Stirm; H Wiegandt
Journal:  Eur J Biochem       Date:  1985-01-02

10.  The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies.

Authors:  U Galili; J Buehler; S B Shohet; B A Macher
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  2 in total

1.  Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis.

Authors:  K Manoutcharian; L I Terrazas; G Gevorkian; G Acero; P Petrossian; M Rodriguez; T Govezensky
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Bovine cysticercosis: demonstration in experimentally infected calves of serum IgG antibodies reactive with neutral glycolipids of Taenia saginata and T. crassiceps metacestodes.

Authors:  S Baumeister; C Schuh; R D Dennis; M Walther; K Pfister; E Geyer
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.